Princy N Kumar

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. ncbi request reprint A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity
    P N Kumar
    Georgetown University Medical Center, Washington, DC 20007, USA
    HIV Med 7:85-98. 2006
  2. pmc A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
    Princy N Kumar
    Georgetown University Medical Center, Washington, DC, USA
    AIDS Res Ther 6:3. 2009
  3. doi request reprint Lamivudine for the treatment of HIV
    Princy N Kumar
    Division of Infectious Diseases, Georgetown University, Washington, DC 20007, USA
    Expert Opin Drug Metab Toxicol 6:105-14. 2010
  4. ncbi request reprint Contemporary role of nevirapine in HIV treatment
    Laura O Coster
    Georgetown University Medical Center, Division of Infectious Diseases, Washington, DC 20007, USA
    AIDS Rev 14:132-44. 2012
  5. doi request reprint Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients
    Jennifer Primeggia
    Georgetown University Medical Center, Division of Infectious Diseases, Department of Medicine, Washington, DC 20007 2113, USA
    Infect Dis Clin North Am 27:473-86. 2013
  6. ncbi request reprint Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy
    Gayle P Balba
    Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA
    Am J Med 119:448.e21-5. 2006

Detail Information

Publications7

  1. ncbi request reprint A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity
    P N Kumar
    Georgetown University Medical Center, Washington, DC 20007, USA
    HIV Med 7:85-98. 2006
    ....
  2. pmc A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
    Princy N Kumar
    Georgetown University Medical Center, Washington, DC, USA
    AIDS Res Ther 6:3. 2009
    ..Both regimens offer benefits in select therapy-naïve subjects. TRIAL REGISTRATION: [Clinical Trials Identifier, NCT00082394]...
  3. doi request reprint Lamivudine for the treatment of HIV
    Princy N Kumar
    Division of Infectious Diseases, Georgetown University, Washington, DC 20007, USA
    Expert Opin Drug Metab Toxicol 6:105-14. 2010
    ..It also has one of the best tolerability and long-term safety profiles among all antiretroviral agents and continues to be preferred as part of initial or subsequent combination therapy in HIV-infected patients...
  4. ncbi request reprint Contemporary role of nevirapine in HIV treatment
    Laura O Coster
    Georgetown University Medical Center, Division of Infectious Diseases, Washington, DC 20007, USA
    AIDS Rev 14:132-44. 2012
    ..This review focuses on current information regarding the role of nevirapine in HAART and defines patient groups whose clinical profiles may warrant consideration of nevirapine...
  5. doi request reprint Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients
    Jennifer Primeggia
    Georgetown University Medical Center, Division of Infectious Diseases, Department of Medicine, Washington, DC 20007 2113, USA
    Infect Dis Clin North Am 27:473-86. 2013
    ..As more antiretroviral regimens are cautiously initiated in the posttransplant period, further research is needed to identify drug-drug interactions to minimize toxicities and improve long-term survival and graft function...
  6. ncbi request reprint Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy
    Gayle P Balba
    Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA
    Am J Med 119:448.e21-5. 2006
    ..From October 2001 to October 2002, we have observed a surprisingly high incidence of ocular syphilis in human immunodeficiency virus-positive (HIV+) patients receiving highly active antiretroviral therapy at our clinic...